Oral Magnesium Supplementation in Chronic Kidney Disease Stages 3 and 4: Efficacy, Safety, and Effect on Serum Calcification Propensity-A Prospective Randomized Double-Blinded Placebo-Controlled Clinical Trial.
about
The effect of magnesium supplementation on vascular calcification in chronic kidney disease-a randomised clinical trial (MAGiCAL-CKD): essential study design and rationale.Therapeutic Interference With Vascular Calcification-Lessons From Klotho-Hypomorphic Mice and Beyond.Magnesium Replacement to Protect Cardiovascular and Kidney Damage? Lack of Prospective Clinical Trials.Deleting Death and Dialysis: Conservative Care of Cardio-Vascular Risk and Kidney Function Loss in Chronic Kidney Disease (CKD).Phosphate, Calcification in Blood, and Mineral Stress: The Physiologic Blood Mineral Buffering System and Its Association with Cardiovascular RiskChallenges in the Diagnosis of Magnesium Status
P2860
Oral Magnesium Supplementation in Chronic Kidney Disease Stages 3 and 4: Efficacy, Safety, and Effect on Serum Calcification Propensity-A Prospective Randomized Double-Blinded Placebo-Controlled Clinical Trial.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Oral Magnesium Supplementation ...... ebo-Controlled Clinical Trial.
@en
Oral Magnesium Supplementation ...... ebo-Controlled Clinical Trial.
@nl
type
label
Oral Magnesium Supplementation ...... ebo-Controlled Clinical Trial.
@en
Oral Magnesium Supplementation ...... ebo-Controlled Clinical Trial.
@nl
prefLabel
Oral Magnesium Supplementation ...... ebo-Controlled Clinical Trial.
@en
Oral Magnesium Supplementation ...... ebo-Controlled Clinical Trial.
@nl
P2093
P2860
P50
P1433
P1476
Oral Magnesium Supplementation ...... ebo-Controlled Clinical Trial.
@en
P2093
Andreas Pasch
Burton Silver
Iain Bressendorff
Lise Pedersen
Morten Schou
Pierre Bouchelouche
P2860
P304
P356
10.1016/J.EKIR.2016.12.008
P577
2016-12-30T00:00:00Z